Independent education resourceInformation here does not replace care from a qualified health professional.
Peptide Therapy GuideClear peptide education

Understand the source comparison

Real Peptides FOXO4-DRI vs Competitors Quality: Comparison Table

Before committing to a supplier, compare these quality markers. They determine whether your FOXO4-DRI produces reproducible results or wastes your sample budget. Synthesis Method Small-batch SPPS with per-cycle Kaiser test verification High-volume liquid-phase

No winner is assigned.

This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.

  • Before committing to a supplier, compare these quality markers. They determine whether your FOXO4-DRI produces reproducible results or wastes your sample budget.
  • Synthesis Method
  • Small-batch SPPS with per-cycle Kaiser test verification
  • High-volume liquid-phase synthesis, post-production sampling only
  • Small-batch SPPS, no per-cycle verification disclosed
  • Real Peptides' per-cycle verification catches sequence errors before final purification. Competitors detect errors only after the batch is complete, if at all
  • Purity Verification
  • Third-party HPLC + MALDI-TOF mass spec on every batch
  • In-house HPLC, single mass spec per product line
  • Third-party HPLC only, mass spec on request
  • Mass spec is non-negotiable for detecting deletion mutants. HPLC alone measures total peptide but not sequence fidelity
  • Endotoxin Testing
  • LAL assay every batch, <1 EU/mg guaranteed
  • Not disclosed, available on request
  • No endotoxin data provided
  • Endotoxin above 1 EU/mg activates NF-κB independently of FOXO4-DRI mechanism. Untested peptides risk false-positive apoptosis results
  • Cold-Chain Shipping
  • Insulated packaging, 2–8°C gel packs, 48-hour delivery, temp data loggers over $500
  • Standard ground shipping, no temperature monitoring
  • Insulated packaging, no temp verification
  • Temperature excursions above 10°C cause irreversible peptide denaturation. Shipping without monitoring means degradation occurs before you open the vial
  • Reconstitution Guidance
  • Detailed protocol with stabiliser recommendations, storage duration specs
  • Basic water/PBS instruction only
  • No reconstitution protocol provided
  • Without stabilisers, reconstituted FOXO4-DRI degrades 30–40% within 72 hours. Proper guidance prevents wasted aliquots
  • Batch-to-Batch Variance
  • <3% purity variance across batches (third-party verified)
  • Not disclosed
  • 5–8% variance (inferred from customer reports)
  • Variance above 5% compromises reproducibility. A 92% pure batch and a 98% pure batch produce different dose-response curves